Literature DB >> 7929496

Adamantinoma of the long bones. A clinicopathological study of thirty-two patients with emphasis on histological subtype, precursor lesion, and biological behavior.

H M Hazelbag1, A H Taminiau, G J Fleuren, P C Hogendoorn.   

Abstract

The records of thirty-two patients who had had an adamantinoma of the long bones were examined to investigate the relationship between the clinical presentation, the histological subtype, and the method of treatment, and the clinical result. All histological patterns of differentiation that are characteristic of adamantinoma were observed, including the basaloid, spindle-cell, tubular, squamous, and osteofibrous dysplasia-like subtypes. Follow-up data were available for twenty-eight (88 per cent) of the thirty-two patients. These patients were followed for a mean duration of 122 months (range, eleven months to twenty-nine years and two months). Nine patients (32 per cent), all of whom had been managed with an intralesional or marginal procedure, had a local recurrence of the tumor after a mean disease developed in three of the nine patients. In five other patients, metastasis developed without having been preceded by a local recurrence. Thus, the over-all rate of metastasis was 29 per cent (eight patients). The mean duration of survival for the patients who had metastasis was twelve years and eight months. Statistical analysis of various clinicopathological variables revealed intralesional or marginal excision to be the most significant risk factor for a local recurrence or metastasis (p < 0.001). Two patients who had had a presumed osteofibrous dysplasia-like adamantinoma, which contained few isolated keratin-positive epithelial cells within the stroma at the time of presentation, had a full-blown adamantinoma at the time of the local recurrence. Although the clinical course that was observed may be the result of a sampling error, it poses questions as to the regressive nature of osteofibrous dysplasia-like adamantinoma. On the basis of our findings and the data in the literature, we believe that an osteofibrous dysplasia-like adamantinoma may be a precursor lesion of the classic type of adamantinoma.

Entities:  

Mesh:

Year:  1994        PMID: 7929496     DOI: 10.2106/00004623-199410000-00008

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  31 in total

Review 1.  Adamantinoma, osteofibrous dysplasia and differentiated adamantinoma.

Authors:  Leonard B Kahn
Journal:  Skeletal Radiol       Date:  2003-03-22       Impact factor: 2.199

2.  Adamantinoma-like Ewing's sarcoma with EWS-FLI1 fusion gene: a case report.

Authors:  Hiromasa Fujii; Kanya Honoki; Yasunori Enomoto; Takahiko Kasai; Akira Kido; Itsuto Amano; Makiko Kumamoto; Toru Morishita; Yoshio Mii; Akitaka Nonomura; Yoshinori Takakura
Journal:  Virchows Arch       Date:  2006-10-03       Impact factor: 4.064

3.  Podoplanin expression in adamantinoma of long bones and osteofibrous dysplasia.

Authors:  Takeshi G Kashima; Arunthati Dongre; Adrienne M Flanagan; Pancras C W Hogendoorn; Richard Taylor; Nicholas A Athanasou
Journal:  Virchows Arch       Date:  2011-04-16       Impact factor: 4.064

Review 4.  Bilateral osteofibrous dysplasia: a report of two cases and review of the literature.

Authors:  U K Sunkara; P D Sponseller; N Hadley Miller; E F McCarthy
Journal:  Iowa Orthop J       Date:  1997

5.  p63 expression in adamantinoma.

Authors:  Brendan C Dickson; Yair Gortzak; Robert S Bell; Peter C Ferguson; David J C Howarth; Jay S Wunder; Rita A Kandel
Journal:  Virchows Arch       Date:  2011-06-15       Impact factor: 4.064

6.  Recurrent adamantinoma in the thoracolumbar spine successfully treated by three-level total en bloc spondylectomy by a single posterior approach.

Authors:  Ping-Guo Duan; Ruo-Yu Li; Yun-Qi Jiang; Hui-Ren Wang; Xiao-Gang Zhou; Xi-Lei Li; Yi-Chao Wang; Jian Dong
Journal:  Eur Spine J       Date:  2014-10-22       Impact factor: 3.134

Review 7.  Benefits of molecular pathology in the diagnosis of musculoskeletal disease : Part II of a two-part review: bone tumors and metabolic disorders.

Authors:  Adrienne M Flanagan; David Delaney; Paul O'Donnell
Journal:  Skeletal Radiol       Date:  2009-08-11       Impact factor: 2.199

8.  Adamantinoma of long bones: a long-term follow-up study of 11 cases.

Authors:  Miklós Szendroi; Imre Antal; Gabriella Arató
Journal:  Pathol Oncol Res       Date:  2008-12-02       Impact factor: 3.201

9.  Osteofibrous dysplasia, osteofibrous dysplasia-like adamantinoma and adamantinoma: correlation of radiological imaging features with surgical histology and assessment of the use of radiology in contributing to needle biopsy diagnosis.

Authors:  Monica Khanna; David Delaney; Roberto Tirabosco; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2008-08-09       Impact factor: 2.199

10.  Adamantinoma: an unusual bone tumour.

Authors:  Pedro Roque; Henry J Mankin; Andrew Rosenberg
Journal:  Chir Organi Mov       Date:  2008-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.